1-[4-[[6-(4-hydroxyphenyl)imidazo[1,5-a]pyridin-8-yl]-methylamino]piperidin-1-yl]prop-2-en-1-one
C22H24N4O2 — CID 154660496
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[[6-(4-hydroxyphenyl)imidazo[1,5-a]pyridin-8-yl]-methylamino]piperidin-1-yl]prop-2-en-1-one
1-[4-[[6-(4-hydroxyphenyl)imidazo[1,5-a]pyridin-8-yl]-methylamino]piperidin-1-yl]prop-2-en-1-one (PubChem CID 154660496) has the molecular formula C22H24N4O2 and a molecular weight of 376.46 g/mol. Its IUPAC name is 1-[4-[[6-(4-hydroxyphenyl)imidazo[1,5-a]pyridin-8-yl]-methylamino]piperidin-1-yl]prop-2-en-1-one.
Molecular Properties
| Compound Name | 1-[4-[[6-(4-hydroxyphenyl)imidazo[1,5-a]pyridin-8-yl]-methylamino]piperidin-1-yl]prop-2-en-1-one |
|---|---|
| PubChem CID | 154660496 |
| Molecular Formula | C22H24N4O2 |
| Molecular Weight | 376.46 g/mol |
| Exact Mass | 376.19 |
| IUPAC Name | 1-[4-[[6-(4-hydroxyphenyl)imidazo[1,5-a]pyridin-8-yl]-methylamino]piperidin-1-yl]prop-2-en-1-one |
| SMILES | C=CC(=O)N1CCC(N(C)c2cc(-c3ccc(O)cc3)cn3cncc23)CC1 |
| InChI | InChI=1S/C22H24N4O2/c1-3-22(28)25-10-8-18(9-11-25)24(2)20-12-17(14-26-15-23-13-21(20)26)16-4-6-19(27)7-5-16/h3-7,12-15,18,27H,1,8-11H2,2H3 |
| InChIKey | LNMZZYSAIRIMSG-UHFFFAOYSA-N |
| XLogP | 3.32 |
| TPSA | 61.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 376.46 |
| LogP ≤ 5 | 3.32 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154660496 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.